JPH09512165A - インターロイキン15 - Google Patents

インターロイキン15

Info

Publication number
JPH09512165A
JPH09512165A JP7526299A JP52629994A JPH09512165A JP H09512165 A JPH09512165 A JP H09512165A JP 7526299 A JP7526299 A JP 7526299A JP 52629994 A JP52629994 A JP 52629994A JP H09512165 A JPH09512165 A JP H09512165A
Authority
JP
Japan
Prior art keywords
polypeptide
dna sequence
host cell
mammalian
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7526299A
Other languages
English (en)
Japanese (ja)
Inventor
グラブスタイン,ケネス・エイチ
アンダーソン,ダーク・エム
エイゼンマン,ジューン・アール
ロウク,チャールズ
ファン,ヴィクター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Priority claimed from PCT/US1994/003793 external-priority patent/WO1995027722A1/en
Priority claimed from ZA942636A external-priority patent/ZA942636B/xx
Publication of JPH09512165A publication Critical patent/JPH09512165A/ja
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP7526299A 1994-04-06 1994-04-06 インターロイキン15 Pending JPH09512165A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1994/003793 WO1995027722A1 (en) 1994-04-06 1994-04-06 Interleukin-15
NZ266264A NZ266264A (en) 1994-04-06 1994-04-06 Mammalian epithelium-derived t-cell factor called interleukin-15
ZA942636A ZA942636B (en) 1994-04-06 1994-04-18 Interleukin-15
OA60897A OA10375A (en) 1994-04-06 1996-09-27 Interleukin-15

Publications (1)

Publication Number Publication Date
JPH09512165A true JPH09512165A (ja) 1997-12-09

Family

ID=33314050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7526299A Pending JPH09512165A (ja) 1994-04-06 1994-04-06 インターロイキン15

Country Status (4)

Country Link
JP (1) JPH09512165A (no)
AU (1) AU680909B2 (no)
FI (1) FI117054B (no)
NO (1) NO318435B1 (no)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010527919A (ja) * 2007-05-11 2010-08-19 アルター・バイオサイエンス・コーポレーション 融合分子及びil−15変異体
JP2017509618A (ja) * 2014-03-03 2017-04-06 サイチューン・ファーマCytune Pharma Il−15/il−15rアルファ系コンジュゲートの精製方法
US11046747B2 (en) 2010-09-21 2021-06-29 Altor Bioscience Llc Multimeric IL-15 soluble fusion molecules and methods of making and using same
US11053299B2 (en) 2010-09-21 2021-07-06 Immunity Bio, Inc. Superkine
WO2021200744A1 (ja) * 2020-03-31 2021-10-07 Cell Exosome Therapeutics株式会社 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤
US11173191B2 (en) 2014-06-30 2021-11-16 Altor BioScience, LLC. IL-15-based molecules and methods of use thereof
US11318201B2 (en) 2016-10-21 2022-05-03 Altor BioScience, LLC. Multimeric IL-15-based molecules

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2986312B1 (en) 2013-04-19 2021-12-15 Cytune Pharma Cytokine derived treatment with reduced vascular leak syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552303A (en) * 1993-03-08 1996-09-03 Immunex Corporation DNA encoding epithelium-derived T-cell factor
US5574138A (en) * 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11365231B2 (en) 2007-05-11 2022-06-21 Altor Bioscience, Llc Interleukin 15 (IL-15) variants
US8940289B2 (en) 2007-05-11 2015-01-27 Altor Bioscience Corporation Fusion molecules and IL-15 variants
US9464127B2 (en) 2007-05-11 2016-10-11 Altor Bioscience Corporation Fusion molecules and IL-15 variants
US9593152B2 (en) 2007-05-11 2017-03-14 Altor Bioscience Corporation Methods of treating disease with fusion molecules comprising IL-15 variants
US10450359B2 (en) 2007-05-11 2019-10-22 Altor Bioscience Corporation IL-15 variants and uses thereof
JP2010527919A (ja) * 2007-05-11 2010-08-19 アルター・バイオサイエンス・コーポレーション 融合分子及びil−15変異体
US11673932B2 (en) 2007-05-11 2023-06-13 Altor BioScience, LLC. Fusion molecules and IL-15 variants
US11498950B1 (en) 2007-05-11 2022-11-15 Altor Bioscience, Llc Fusion molecules and IL-15 variants
US11845783B2 (en) 2010-09-21 2023-12-19 Altor BioScience, LLC. Multimeric IL-15 soluble fusion molecules and methods of making and using same
US11046747B2 (en) 2010-09-21 2021-06-29 Altor Bioscience Llc Multimeric IL-15 soluble fusion molecules and methods of making and using same
US11053299B2 (en) 2010-09-21 2021-07-06 Immunity Bio, Inc. Superkine
US11104716B2 (en) 2010-09-21 2021-08-31 Altor BioScience, LLC. Multimeric IL-15 soluble fusion molecules and methods of making and using same
JP2020063288A (ja) * 2014-03-03 2020-04-23 サイチューン ファーマ Il−15/il−15rアルファ系コンジュゲートの精製方法
JP2017509618A (ja) * 2014-03-03 2017-04-06 サイチューン・ファーマCytune Pharma Il−15/il−15rアルファ系コンジュゲートの精製方法
US11471511B2 (en) 2014-06-30 2022-10-18 Altor Bioscience, Llc IL-15-based molecules and methods of use thereof
US11173191B2 (en) 2014-06-30 2021-11-16 Altor BioScience, LLC. IL-15-based molecules and methods of use thereof
US11679144B2 (en) 2014-06-30 2023-06-20 Altor BioScience, LLC. IL-15-based molecules and methods of use thereof
US11890323B2 (en) 2014-06-30 2024-02-06 Altor Bioscience, Llc Method of treating cancer with composition comprising IL-15-based molecules and BCG
US11925676B2 (en) 2014-06-30 2024-03-12 Altor BioScience, LLC. Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex
US11992516B2 (en) 2014-06-30 2024-05-28 Altor BioScience, LLC. Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies
US12097244B2 (en) 2014-06-30 2024-09-24 Altor BioScience, LLC. Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody
US11318201B2 (en) 2016-10-21 2022-05-03 Altor BioScience, LLC. Multimeric IL-15-based molecules
US11369679B2 (en) 2016-10-21 2022-06-28 Altor Bioscience, Llc Multimeric IL-15-based molecules
JP2022181218A (ja) * 2020-03-31 2022-12-07 Cell Exosome Therapeutics株式会社 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤
WO2021200744A1 (ja) * 2020-03-31 2021-10-07 Cell Exosome Therapeutics株式会社 増殖細胞の生産方法、細胞生産物の生産方法、間葉系幹細胞集団およびその生産方法、幹細胞の培養上清およびその生産方法、並びに治療剤

Also Published As

Publication number Publication date
FI117054B (fi) 2006-05-31
NO964141D0 (no) 1996-09-30
NO318435B1 (no) 2005-03-21
NO964141L (no) 1996-12-06
FI963828A0 (fi) 1996-09-25
AU680909B2 (en) 1997-08-14
AU6767394A (en) 1995-10-30
FI963828A (fi) 1996-12-02

Similar Documents

Publication Publication Date Title
EP0772624B1 (en) Interleukin-15
US5552303A (en) DNA encoding epithelium-derived T-cell factor
US5985262A (en) Method of treatment with epithelium derived T-cell factor
AU646881B2 (en) Adoptive immunotherapy with interleukin-7
KR100607609B1 (ko) Il-2 선택성 작용제 및 길항제
US7875709B2 (en) Nucleic acids encoding interleukin-18 mutants
JP2002514887A (ja) トロンボポイエチンポリペプチドの分泌方法
FI103987B (fi) Interleukiini-7
KR100496460B1 (ko) 폴리펩티드
AU2002324249A1 (en) Interleukin-18 mutants, their production and use
JPH09512165A (ja) インターロイキン15
AU620537B2 (en) Human interleukin-4 muteins
US20080090762A1 (en) Epithelum-derived T-cell factor
JP3689111B2 (ja) インターロイキン15
Devereux et al. Granulocyte-macrophage colony-stimulating factor